Antivirals Market Anticipated To Witness Robust Growth, Surpassing $153.67 Billion By 2029

The Antivirals Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Current Antivirals Market Size and Its Estimated Growth Rate?
The antivirals market has recorded strong growth over recent years, forecasted to grow from $106.13 billion in 2024 to $114.7 billion in 2025, at a CAGR of 8.1%. Factors behind past growth include the prevalence of viral illnesses, health-related concerns, patent expirations, and governmental support.

The antivirals market is anticipated to grow strongly in the near future. It will reach $153.67 billion by 2029 at a compound annual growth rate (CAGR) of 7.6%. This market expansion can be attributed to the emergence of new viral threats and global health initiatives. Key trends during this period include technological innovations, the rise of telemedicine and digital health solutions, and advancements in personalized medicine.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2437

How Are Emerging Segments Shaping the Antivirals Market Landscape?
The antivirals market covered in this report is segmented -

1) By Type: Branded, Generic
2) By Drug Class: DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors, Other Drug classes
3) By Application: HIV, Hepatitis, Herpes, Influenza, Other Applications

Subsegments:
1) By Branded: Antivirals For HIV Or AIDS, Antivirals For Hepatitis, Antivirals For Influenza, Antivirals For Herpes Simplex Virus (HSV)
2) By Generic: Generic HIV Or AIDS Antivirals, Generic Hepatitis Antivirals, Generic Influenza Antivirals, Generic Herpes Simplex Virus (HSV) Antivirals

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2437&type=smp

Which Growth Factors Are Influencing Antivirals Market Expansion?
The growing number of influenza cases is expected to support the expansion of the antiviral market. Influenza, a contagious respiratory illness caused by influenza viruses, affects the nose, throat, and lungs, and antivirals are crucial for treating it by hindering viral replication. For example, in October 2022, the Centers for Disease Control and Prevention reported that during the 2021-2022 season, there were 9 million flu cases, 4 million related medical visits, 100,000 hospitalizations, and 5,000 deaths in the US. Hence, the rising incidence of influenza is fueling the antiviral market's growth.

Who Are the Dominant Players Across Different Antivirals Market Segments?
Major companies operating in the antivirals market include AbbVie Inc., Bristol-Myers-Squibb Co., Chemical Industrial & Pharmaceutical Laboratories Ltd., F. Hoffmann-La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline Plc, Johnson & Johnson Services Ltd., Merck & Co. Inc., Dr. Reddy's Laboratories Ltd., AstraZeneca plc, Aurobindo Pharma Ltd., Abbott Laboratories, Schering-Plough Corporation, Pfizer Inc., Sanofi-Synthélabo Ltd., Regeneron Pharmaceuticals Inc., Inovio Pharmaceuticals Inc., Novavax Inc., BioCryst Pharmaceuticals Inc., Alnylam Pharmaceuticals Inc., Argos Distributors Limited, AVI Biopharma International Ltd., Moderna Inc., BioNTech SE, Eli Lilly and Company, Takeda Pharmaceutical Company Limited, Biogen Inc., Genentech USA Inc., Vertex Pharmaceuticals Inc.

What Are the Latest Developing Trends in the Antivirals Market?
Leading companies in the antiviral market are developing innovative oral antiviral treatments to enhance patient compliance, reduce TH*Care costs, and provide easier options for managing viral infections. In May 2023, Pfizer's Paxlovid, an oral treatment for COVID-19, was approved by the FDA. This approval marks a significant step in treating mild-to-moderate COVID-19 in high-risk adults and provides an alternative to more complex treatment regimens.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/antivirals-global-market-report

Which Geographic Regions Are Expected to Dominate the Antivirals Market in the Coming Years?
North America was the largest region in the anti-viral drug therapy market in 2023. The Middle East is expected to be the fastest-growing region in the antivirals market during the forecast period. The regions covered in the antivirals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Antivirals Market?
2. What is the CAGR expected in the Antivirals Market?
3. What Are the Key Innovations Transforming the Antivirals Industry?
4. Which Region Is Leading the Antivirals Market?

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.